VENOUS THROMBOEMBOLISM. PRACTITIONER SUMMARY

Authors

  • A.A. Irnazarov Tashkent Medical Academy
  • S.U. Rakhmanov Tashkent Medical Academy
  • V.R. Khasanov Tashkent Medical Academy

Keywords:

deep vein thrombosis, pulmonary embolism, thromboprophylaxis using low molecular weight heparins, treatment.

Abstract

In recent years, the term “venous thromboembolism” has been increasingly used in clinical practice, combining two
pathogenetically related diseases - deep vein thrombosis (DVT) and pulmonary embolism (pulmonary embolism). As
observations show, after the first episode of DVT, post-thrombotic syndrome develops within 2 years in 60% of patients.
If untreated, half of the patients develop asymptomatic pulmonary embolism. One quarter of patients experience a
relapse of venous thromboembolism over the next 5 years, especially with cancer or blood clotting disorders. Patients
with complications of therapeutic diseases may be at risk of developing venous thrombosis and embolism. Therefore,
extremely early diagnosis of these patients, effective treatment and prevention are extremely important.

Downloads

Published

2020-07-08

How to Cite

Irnazarov, A., Rakhmanov, S., & Khasanov, V. (2020). VENOUS THROMBOEMBOLISM. PRACTITIONER SUMMARY. Toshkent Tibbiyot Akademiyasi Axborotnomasi, (5), 166-171. Retrieved from https://journals.tma.uz/index.php/ttaa/article/view/133

Issue

Section

To Help A Practical Doctor